Genetic
1964 CE — Finland, de la Chapelle et al. clinical report
XX male syndrome was a chromosomal condition in which individuals with two X chromosomes developed a male phenotype, a phenomenon that confounded early twentieth-century geneticists accustomed to viewing the Y chromosome as the absolute determinant of male development. The condition was first characterized as a clinical entity in 1964, though its existence had been inferred from scattered case reports of individuals whose sex chromosome constitution defied the expected pattern. Molecular investigations in subsequent decades traced the underlying mechanism to the translocation of sex-determining genetic material from the Y chromosome onto the X chromosome or an autosome.
Historical Narrative
The scientific framework necessary for understanding XX male syndrome did not exist until the twentieth century, as the very concept of chromosomes as carriers of hereditary information only began taking shape in the early 1900s following the rediscovery of Mendel's laws and the cytological work of researchers such as Walter Sutton and Theodor Boveri. Prior to this period, individuals who would later be recognized as having sex chromosome anomalies were understood, when noticed at all, through social and medical categories entirely unrelated to genetics.
The identification of sex chromosomes themselves was accomplished by Nettie Stevens and Edmund Beecher Wilson in 1905, when their independent cytological observations established that males and females differed in a specific chromosome pair. Stevens working at Bryn Mawr College demonstrated in the mealworm Tenebrio that males carried one large and one small chromosome where females carried two large ones, providing the first clear cytological evidence of chromosomal sex determination.
For the following decades, the Y chromosome was assumed to function essentially as a passive or inert chromosome, with maleness arising from the absence of a second X rather than from positive genetic instructions carried on the Y. This 'X dosage' hypothesis persisted well into the mid-twentieth century and shaped how geneticists interpreted anomalous cases.
The development of reliable human karyotyping techniques by Joe Hin Tjio and Albert Levan in 1956, who correctly established the human chromosome number as 46, opened the door to systematic investigation of chromosomal conditions in clinical patients. Within a few years, karyotyping was applied to individuals with ambiguous or unexpected sex characteristics, leading to the discovery of conditions such as Klinefelter syndrome (reported by Harry Klinefelter in 1942 based on clinical features and later confirmed chromosomally) and Turner syndrome.
XX male syndrome as a distinct entity was formally described in 1964 by Chapelle, Hortling, Niemi, and Wennström in a Finnish research group, who reported males confirmed to carry a 46,XX karyotype. The discovery was scientifically startling because it demonstrated that a Y chromosome was not strictly necessary for male anatomical development, challenging the prevailing chromosomal determinism model directly.
Subsequent research throughout the 1960s and 1970s focused intensely on identifying what factor present in normal males but apparently absent from the genome of XX males might account for sex determination. The testis-determining factor, hypothesized as a protein product of a Y-linked gene, became a central object of investigation. Gerald Schaaffhausen and later researchers pursued biochemical and genetic approaches, while H-Y antigen, a cell-surface molecule initially discovered by Eichwald and Silmser in mice, was proposed in the 1970s as a candidate for this sex-determining role.
The molecular resolution came in the 1980s and 1990s when advances in recombinant DNA technology allowed detailed mapping of the human Y chromosome. David Page and colleagues at the Whitehead Institute reported in 1987 the identification of a Y-linked gene they designated ZFY as a strong candidate for the testis-determining factor, and while ZFY was subsequently shown not to fulfill that role, their work set the methodological stage for the identification of SRY by Peter Goodfellow, Robin Lovell-Badge, and colleagues in 1990. Analysis of XX males revealed that a significant proportion carried small translocations of Y chromosomal material including this gene onto their X chromosomes, providing the molecular explanation for how testicular development could occur in the apparent absence of a Y chromosome.
Key Historical Figures
Historical narrative only — this page describes how XX male syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.